title: Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study.
abstract: Clonazepam seems to be an effective drug in idiopathic trigeminal neuralgia. Electrophysiological investigations support the idea that this neuralgia is due to a loss of central inhibition. During the first 1-2 weeks of treatment marked drowsiness is observed in the majority of cases. In one case, presence of a synergism between Clonazepam and L-dopa+ inhibitor was also observed.
mesh_terms: D000328:Adult; D000368:Aged; D001570:Benzodiazepinones / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D002998:Clonazepam / Q000627:therapeutic use*; D005260:Female; D006261:Headache / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014277:Trigeminal Neuralgia / Q000188:drug therapy*; D014653:Vascular Headaches / Q000188:drug therapy*
chemical_list: D001570:Benzodiazepinones; D002998:Clonazepam